Home › Calculator › NVO Dividend Calculator 2026
NVO Dividend DRIP Calculator 2026
3.69% YieldHealthcareNovo Nordisk A/S · NYSE
Price: $48.89 · Annual div: $1.80/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Calculator settings
Portfolio growth: DRIP vs No DRIP
Annual dividend income growth
💡 What-if scenarios
Click to apply scenario to the calculator
🎯 When NVO pays your bills
Year your monthly dividend income covers each expense (based on current settings)
Share your NVO snowball 📈
$10,000 in NVO → $14.71M in 10 years · $43,554.45/month
About Novo Nordisk A/S (NVO) — Dividend Analysis 2026
Novo Nordisk A/S is a global pharmaceutical firm dedicated to the investigation, creation, manufacturing, and distribution of medicinal products across a vast international footprint. Its market presence extends throughout Europe, the Middle East, Africa, various parts of Asia (including Mainland China, Hong Kong, and Taiwan), and North America. The company's operations are structured into two principal business units: Diabetes and Obesity Care, and Rare Disease. The Diabetes and Obesity Care division delivers therapies for diabetes, obesity, cardiovascular ailments, and other emerging therapeutic areas. Meanwhile, the Rare Disease division concentrates on providing treatments for rare blood disorders, uncommon endocrine conditions, and hormone replacement solutions. In addition to its core pharmaceutical offerings, Novo Nordisk produces specialized medical equipment such as insulin pens, growth hormone pens, and injection needles. It also pioneers smart digital solutions for diabetes management, including advanced insulin pens and the Dose Check application, designed to guide insulin dosage. The company engages in strategic alliances, notably a partnership with UNICEF to combat childhood obesity and a collaboration with Valo Health, Inc. to discover and advance novel drug pipelines in the cardiometabolic space. Founded in 1923, Novo Nordisk A/S is headquartered in Bagsvaerd, Denmark.
Compare NVO with similar stocks
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
Get Your Full NVO DRIP Report by Email
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open NVO position with:
🌍 NVO Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold NVO.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 3.69% | 0.89% | $369 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 3.14% | 0.34% | $314 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 2.95% | 0.15% | $295 / yr |
| 🇬🇧 UK ISA | 0% | 3.69% | 0.89% | $369 / yr |
| 🇬🇧 UK Taxable | 8.75% | 3.37% | 0.57% | $337 / yr |
| 🇨🇦 TFSA | 0% | 3.69% | 0.89% | $369 / yr |
| 🇨🇦 CA Taxable | 25% | 2.77% | -0.03% | $277 / yr |
| 🇦🇺 Super (pension) | 15% | 3.14% | 0.34% | $314 / yr |
| 🇦🇺 AU Taxable | 30% | 2.58% | -0.22% | $258 / yr |
| 🇩🇪 DE Taxable | 26.375% | 2.72% | -0.08% | $272 / yr |
| 🇫🇷 FR Taxable | 30% | 2.58% | -0.22% | $258 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 NVO Income Goal & Break-Even
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $1.80/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 NVO Dividend Payment Schedule
NVO pays quarterly — 4 times per year. Next ex-div: TBD.
📊 NVO vs Healthcare Benchmarks
How NVO compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for NVO sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ NVO Insider Activity
No recent SEC filings reported in the last 90 days.Analyst Price Target
Wall Street consensusAnalyst consensus price target via FMP. Not a guarantee of future performance. Past analyst accuracy varies.
Financial Health Scores
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Geographic Revenue Breakdown
Where NVO earns its moneyRevenue breakdown from latest annual report via FMP. Percentages may not sum to 100% due to rounding.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the NVO dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Novo Nordisk A/S (NVO) is currently trading at $48.89, 66% below its 52-week high. The current dividend yield is 3.69% based on an annual payout of $1.80 per share.
NVO (Novo Nordisk A/S) — 3.69% Dividend Yield Analysis
Novo Nordisk A/S (NVO) is a healthcare stock currently trading at $48.89 with a dividend yield of 3.69%. The company pays an annual dividend of $1.80 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings. Over the past 5 years, NVO has grown its dividend at a compound annual rate of 100.0%.
- Dividend payments are not guaranteed and can be reduced or suspended at any time.
Auto-generated from live market data. For educational purposes only — not financial advice.